🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
The purpose of this study is to assess the effect of food on the bioavailab...
Status
Completed
Location
Prism Research Site Number : 8400001
Start Date
2020-06-18
Trial ID
NCT06418620
Treatments Being Tested
This study is intended to estimate the bioavailability of a single 100 mg b...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2022-01-19
Trial ID
NCT05032690
Treatments Being Tested
The purpose of this study is to determine the relative oral bioavailability...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00946842
Treatments Being Tested
The purpose of this study is to assess the effect of antacid administration...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02382640
Treatments Being Tested
This is a phase 1, randomised, open-label, three-way, three-period, crossov...
Status
Active Not Recruiting
Location
Fuzhou University Affiliated Provincial Hospital
Start Date
2026-06-08
Trial ID
NCT07610148
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested
2 different formulations and 4 different single doses of tafamidis will be ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-28
Trial ID
NCT03662191
Treatments Being Tested
The main objective of this trial is to investigate relative bioavailability...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2025-02-10
Trial ID
NCT06772532
Treatments Being Tested
DREAM-03 is an early phase-1, open label study to compare the safety, pharm...
Status
Completed
Location
Johns Hopkins University
Start Date
2020-01-10
Trial ID
NCT04016233
Treatments Being Tested